- Home
- APT vs IMMX Comparison
APT vs IMMX Comparison
Compare APT & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- IMMX
- Stock Information
- Founded
- APT 1983
- IMMX 2014
- Country
- APT Canada
- IMMX United States
- Employees
- APT N/A
- IMMX N/A
- Industry
- APT
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- APT
- IMMX Health Care
- Exchange
- APT Nasdaq
- IMMX Nasdaq
- Market Cap
- APT 61.6M
- IMMX 54.9M
- IPO Year
- APT 1995
- IMMX 2021
- Fundamental
- Price
- APT $4.56
- IMMX $2.37
- Analyst Decision
- APT
- IMMX Strong Buy
- Analyst Count
- APT 0
- IMMX 1
- Target Price
- APT N/A
- IMMX $7.00
- AVG Volume (30 Days)
- APT 42.1K
- IMMX 500.4K
- Earning Date
- APT 05-08-2025
- IMMX 06-17-2025
- Dividend Yield
- APT N/A
- IMMX N/A
- EPS Growth
- APT 2.28
- IMMX N/A
- EPS
- APT 0.36
- IMMX N/A
- Revenue
- APT $58,180,000.00
- IMMX N/A
- Revenue This Year
- APT N/A
- IMMX N/A
- Revenue Next Year
- APT N/A
- IMMX N/A
- P/E Ratio
- APT $12.84
- IMMX N/A
- Revenue Growth
- APT N/A
- IMMX N/A
- 52 Week Low
- APT $4.06
- IMMX $1.26
- 52 Week High
- APT $6.44
- IMMX $3.00
- Technical
- Relative Strength Index (RSI)
- APT 47.84
- IMMX 57.46
- Support Level
- APT $4.25
- IMMX $1.87
- Resistance Level
- APT $5.16
- IMMX $3.00
- Average True Range (ATR)
- APT 0.23
- IMMX 0.27
- MACD
- APT 0.01
- IMMX 0.00
- Stochastic Oscillator
- APT 34.07
- IMMX 44.25
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is involved in the business of developing, manufacturing, and marketing of disposable protective apparel, building supply, and infection control products principally in the United States. It operates its business through segment which includes Building Supply and Disposable Protective Apparel. It mainly offers a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment as well as other woven material, different styles of disposable products like shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. It also provides face masks and eye shields. It generates most of its revenues from the sale of products across the United States.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.